The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1-Reference-Cited by-同舟云学术

The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1

Published:2014-07 Issue:30 Volume:289 Page:21082-21097
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Janes Kali,Little Joshua W.,Li Chao,Bryant Leesa,Chen Collin,Chen Zhoumou,Kamocki Krzysztof,Doyle Timothy,Snider Ashley,Esposito Emanuela,Cuzzocrea Salvatore,Bieberich Erhard,Obeid Lina,Petrache Irina,Nicol Grant,Neumann William L.,Salvemini Daniela

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference93 articles.

1. Chemotherapy-induced neuropathic pain;Farquhar-Smith;Curr. Opin. Support Palliat. Care,2011

2. Biologically active sphingolipids in cancer pathogenesis and treatment;Ogretmen;Nat. Rev. Cancer,2004

3. The outs and the ins of sphingosine-1-phosphate in immunity;Spiegel;Nat. Rev. Immunol,2011

4. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network;Rosen;Nat. Rev. Immunol,2005

5. Novel agents targeting bioactive sphingolipids for the treatment of cancer;Adan-Gokbulut;Curr. Med. Chem,2013

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients;2024-08-22

2. Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients;2024-08-22

3. FTY720/Fingolimod mitigates paclitaxel‐induced Sparcl1‐driven neuropathic pain and breast cancer progression;The FASEB Journal;2024-08-10

4. HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain;Inflammopharmacology;2024-05-18

5. Bortezomib-induced peripheral neuropathy: Clinical features, molecular basis, and therapeutic approach;Critical Reviews in Oncology/Hematology;2024-05